Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
336 JPY | -5.35% | -17.44% | -27.90% |
May. 09 | Sumitomo Pharma Co., Ltd. agreed to acquire MELTz Business of MELTIN MMI Co., Ltd. | CI |
May. 07 | Profit-Taking, China Outlooks Churn Asian Stock Markets | MT |
Business Summary
- pharmaceuticals (92.9%): for cardiovascular, gastrointestinal and infectious diseases, central nervous systems disorders and allergies treatment;
- other (7.1%): veterinary drugs, food additives, industrial chemical products, etc.
Net sales are distributed geographically as follows: Japan (39.8%), the United States (50.4%), North America (0.9%) and other (8.9%).
Number of employees: 6,250
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
91.9
%
| 520,177 | 92.9 % | 510,722 | 91.9 % | -1.82% |
Other
8.1
%
| 39,858 | 7.1 % | 44,822 | 8.1 % | +12.45% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
59.1
%
| 319,790 | 57.1 % | 328,467 | 59.1 % | +2.71% |
Japan
22.7
%
| 149,915 | 26.8 % | 126,106 | 22.7 % | -15.88% |
Global
8.1
%
| 39,858 | 7.1 % | 44,822 | 8.1 % | +12.45% |
China
7.1
%
| 38,296 | 6.8 % | 39,397 | 7.1 % | +2.87% |
Other Overseas
3.0
%
| 12,176 | 2.2 % | 16,752 | 3.0 % | +37.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hiroshi Nomura
CEO | Chief Executive Officer | 66 | 05-09-30 |
Masayo Tada
CHM | Chairman | 79 | 05-09-30 |
Yoshiharu Ikeda
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kenji Ueno
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isao Shimizu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Yutaka Atomi
BRD | Director/Board Member | 79 | 13-05-31 |
Nobuhiko Tamura
BRD | Director/Board Member | 68 | 09-10-31 |
Toru Kimura
BRD | Director/Board Member | 63 | 09-05-31 |
Hitoshi Odagiri
BRD | Director/Board Member | 67 | 12-03-31 |
Atsuko Higuchi
IRO | Public Communications Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Saeko Arai
BRD | Director/Board Member | 60 | 18-05-31 |
Nobuhiro Endo
BRD | Director/Board Member | 70 | 19-05-31 |
Masayo Tada
CHM | Chairman | 79 | 05-09-30 |
Minoru Usui
BRD | Director/Board Member | 69 | - |
Nobuhiko Tamura
BRD | Director/Board Member | 68 | 09-10-31 |
Yoshiharu Ikeda
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hiroshi Nomura
CEO | Chief Executive Officer | 66 | 05-09-30 |
Hitoshi Odagiri
BRD | Director/Board Member | 67 | 12-03-31 |
Toru Kimura
BRD | Director/Board Member | 63 | 09-05-31 |
Yutaka Atomi
BRD | Director/Board Member | 79 | 13-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 397,900,154 | 168,148,626 ( 42.26 %) | 609,393 ( 0.1532 %) | 42.26 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
3,250,383 | 1.47% | 51,017,979 $ | |
1,641,120 | 0.81% | 24,361,557 $ | |
1,665,000 | 0.33% | 24,081,211 $ | |
3,400,000 | 2.62% | 17,608,736 $ | |
TOHO HOLDINGS CO., LTD. 0.76% | 578,426 | 0.76% | 13,868,405 $ |
541,600 | 1.45% | 10,978,958 $ | |
VITAL KSK HOLDINGS, INC. 2.31% | 1,199,000 | 2.31% | 9,394,513 $ |
THE SHIGA BANK, LTD. 0.21% | 112,400 | 0.21% | 2,914,194 $ |
468,000 | 1.92% | 2,548,700 $ | |
608,700 | 0.15% | 1,543,365 $ |
Company contact information
Sumitomo Pharma Co., Ltd.
2-6-8 Dosho-machi Chuo-Ku
541-0045, Osaka
+81 6 6203 5321
http://www.sumitomo-pharma.co.jpSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.90% | 859M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 4506 Stock
- Company Sumitomo Pharma Co., Ltd.